©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 7, 2013; 19(21): 3255-3262
Published online Jun 7, 2013. doi: 10.3748/wjg.v19.i21.3255
Published online Jun 7, 2013. doi: 10.3748/wjg.v19.i21.3255
Table 3 Reported liver-related and treatment-related adverse events
| Non-liver transplanted cirrhotics | Liver transplanted cirrhotics | |
| Intolerance (fatigue, flu-like symptoms, depression) | ||
| Grade 2 | 1 | 0 |
| Grade 3 | 3 | 0 |
| Anemia | ||
| Grade 1 | 12 | 0 |
| Grade 2 | 2 | 4 |
| Grade 3 | 0 | 2 |
| Neutropenia | ||
| Grade 2 | 0 | 2 |
| Grade 3 | 6 | 1 |
| Liver decompensation | ||
| Grade 1 (encephalopathy) | 0 | 1 |
| Other | ||
| Hepatocellular carcinoma | 2 | 0 |
| Polytrauma | 1 | 0 |
- Citation: Ponziani FR, Annicchiarico EB, Siciliano M, D’Aversa F, Pompili M, Gasbarrini A. Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation. World J Gastroenterol 2013; 19(21): 3255-3262
- URL: https://www.wjgnet.com/1007-9327/full/v19/i21/3255.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i21.3255